Mackenzie Financial
EDIT icon

Mackenzie Financial’s Editas Medicine EDIT Stock Holding History

Mackenzie Financial’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.84M Buy
878,042
+147,988
+20% +$433K ﹤0.01% 972
2026
Q1 		$1.8M Buy
+730,054
New +$1.54M ﹤0.01% 949

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Mackenzie Financial's EDIT Position: Q2 2026 in Review

Mackenzie Financial increased its Editas Medicine (EDIT) stake by 20% in Q2 2026, buying an estimated $433K and bringing the position to 878,042 shares worth $2.84M. The position accounts for ﹤0.01% of the portfolio, ranked #972.

Mackenzie Financial first reported a position in EDIT in Q1 2026 and has held it in 2 quarters since. 214 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Mackenzie Financial held 878,042 shares of Editas Medicine worth $2.84M as of Q2 2026.
  • Mackenzie Financial bought 147,988 Editas Medicine shares in Q2 2026, an estimated $433K.
  • Editas Medicine made up ﹤0.01% of Mackenzie Financial's portfolio in Q2 2026, its #972 holding.
  • Mackenzie Financial first reported a position in Editas Medicine in Q1 2026 and has held it in 2 quarters since.
  • 214 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Mackenzie Financial's 13F filing for Q2 2026, filed 13 Aug 2026.